A 62 year old ex-smoker with GOLD stage 3 COPD has persistent dyspnoea despite regular short-acting bronchodilator use. He has had two exacerbations r...

Question

A 62 year old ex-smoker with GOLD stage 3 COPD has persistent dyspnoea despite regular short-acting bronchodilator use. He has had two exacerbations requiring steroids in the past year. Which long-term pharmacological strategy is preferred?

Accepted Answer

Start long-acting muscarinic antagonist or long-acting beta-agonist inhaler

Answer

Start inhaled corticosteroid monotherapy

Answer

Start oral theophylline as first-line

Answer

Start long-term oral prednisolone

Answer

No escalation is indicated

au-racgp MCQ (SBA): COPD long-acting bronchodilator choice

A 62 year old ex-smoker with GOLD stage 3 COPD has persistent dyspnoea despite regular short-acting bronchodilator use. He has had two exacerbations requiring steroids in the past year. Which long-term pharmacological strategy is preferred?